BOLERO-2: EVEROLIMUS IN COMBINATION WITH EXEMESTANE IN THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH ESTROGEN RECEPTOR-POSITIVE ADVANCED BREAST CANCER REFRACTORY TO LETROZOLE OR ANASTROZOLE

被引：0

作者：

Campone, Mario ^{[1
]}

Piccart, Martine ^{[2
]}

Pritchard, Kathleen I. ^{[3
,4
]}

Xu, Cindy ^{[5
]}

Gnant, Michael ^{[6
]}

Neven, Patrick ^{[7
]}

Pistilli, Barbara ^{[8
]}

Shtivelband, Mikhail ^{[9
]}

Provencher, Louise ^{[10
]}

Masuda, Norikazu ^{[11
]}

El-Hashimy, Mona ^{[5
]}

Vittori, Luc ^{[12
]}

Sahmoud, Tarek ^{[5
]}

Baselga, Jose ^{[13
]}

Hortobagyi, Gabriel N. ^{[14
]}

机构：

[1] Ctr Reg Rene Gauducheau, St Herblain, France

[2] Inst Jules Bordet, B-1000 Brussels, Belgium

[3] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada

[4] Univ Toronto, Toronto, ON, Canada

[5] Novartis Pharmaceut, Florham Pk, NJ USA

[6] Med Univ Vienna, Vienna, Austria

[7] Catholic Univ Louvain, UZ Leuven, B-3000 Louvain, Belgium

[8] Macerata Hosp, Dept Oncol, Macerata, MC, Italy

[9] Ironwood Canc & Res Ctr, Chandler, AZ USA

[10] Hop St Sacrement, Quebec City, PQ, Canada

[11] Osaka Natl Hosp, Osaka, Japan

[12] Novartis Pharma AG, Basel, Switzerland

[13] Massachusetts Gen Hosp, Boston, MA 02114 USA

[14] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

BREAST | 2011年 / 20卷

关键词：

D O I：

10.1016/j.breast.2011.08.052

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S30 / S30

页数：1

共 50 条

[31] MANAGEMENT OF EVEROLIMUS-RELATED ADVERSE EVENTS IN POSTMENOPAUSAL WOMEN WITH ESTROGEN RECEPTOR-POSITIVE ADVANCED BREAST CANCER.
Peterson, Mary
ONCOLOGY NURSING FORUM, 2012, 39 (03) : E188 - E188
[32] UPDATED RESULTS OF THE BOLERO-2 PHASE III TRIAL EVALUATING EVEROLIMUS (EVE) FOR POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST CANCER (ABC)
Rugo, H.
Piccart, M.
Hortobagyi, G.
Noguchi, S.
Gnant, M.
Campone, M.
Bauly, H.
Mukhopadhyay, P.
Sahmoud, T.
Baselga, J.
ANNALS OF ONCOLOGY, 2012, 23 : 46 - 46
[33] Safety of everolimus in estrogen receptor-positive advanced breast cancer.
Perez, Alejandra T.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
[34] A short-term neoadjuvant pilot study comparing exemestane and letrozole in postmenopausal women with estrogen receptor-positive HER2-negative breast cancer
Miura, Daishu
Iwatani, Tsuguo
Kawabata, Hidetaka
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[35] EFFICACY AND SAFETY OF EVEROLIMUS IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST CANCER (BOLERO-2): EFFECT OF VISCERAL METASTASES AND PRIOR ENDOCRINE THERAPY
Campone, M.
Noguchi, S.
Pritchard, K.
Rugo, H.
Hortobagyi, G. N.
Baselga, J.
Panneerselvam, A.
Taran, T.
Sahmoud, T.
Piccart, M.
ANNALS OF ONCOLOGY, 2012, 23 : 118 - 118
[36] Characterization of response to everolimus (EVE) in BOLERO-2: A phase 3 trial of EVE plus exemestane (EXE) in postmenopausal women with HR+, HER2-advanced breast cancer
Burris, H.
Gnant, M.
Hortobagyi, G.
Hart, L.
Yardley, D. A.
Eakle, J.
Provencher, L.
Brechenmacher, T.
Saletan, S.
Taran, T.
Rugo, H.
CANCER RESEARCH, 2013, 73
[37] Comparison of cost-effectiveness of aromatase inhibitors letrozole, anastrozole or exemestane versus tamoxifen for early breast cancer in hormone receptor-positive postmenopausal women: Canadian perspective
El Ouagari, K.
Kamon, J.
Kaura, S.
EJC SUPPLEMENTS, 2007, 5 (04): : 210 - 211
[38] Complete estrogen blockade in advanced postmenopausal receptor-positive breast cancer
Nature Clinical Practice Oncology, 2008, 5 (2): : 67 - 67
[39] Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Stearns, Vered
Brufsky, Adam M.
Verma, Shailendra
Cotter, Matthew J.
Lu, Dongrui R.
Dequen, Florence
Joy, Anil Abraham
CLINICAL BREAST CANCER, 2018, 18 (06) : E1239 - E1245
[40] Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2
Piccart, M.
Hortobagyi, G. N.
Campone, M.
Pritchard, K. I.
Lebrun, F.
Ito, Y.
Noguchi, S.
Perez, A.
Rugo, H. S.
Deleu, I.
Burris, H. A., III
Provencher, L.
Neven, P.
Gnant, M.
Shtivelband, M.
Wu, C.
Fan, J.
Feng, W.
Taran, T.
Baselga, J.
ANNALS OF ONCOLOGY, 2014, 25 (12) : 2357 - 2362

← 1 2 3 4 5 →